News
-
23 May 2012 /Side effects and trials
Increased risk of cardiac arrest associated with the use of TCA and SSRI antidepressants
A new Danish study has found an increased risk of cardiac arrest associated with treatment with TCAs (tricyclic antidepressants) or SSRIs (selective serotonin reuptake inhibitors). The study found no association between increased risk of cardiac arrest and the use of SNRI antidepressants (serotonin and norepinephrine reuptake inhibitors) or NaSSA antidepressants (noradrenergic and specific serotonergic antidepressants).
-
15 May 2012 /Side effects and trials
Pradaxa – consider age and follow dose recommendations
In March, in collaboration with the Thrombosis Centre in Aalborg, the Danish Health and Medicines Authority published an evaluation of all adverse reaction reports in Danish Pharmacovigilance Update for the period 22 August 2011 up to and including 23 February 2012 in connection with a new indication (prevention of apoplexy in patients with non-valvular atrial fibrillation) for Pradaxa® (dabigatran etexilate). With this announcement, we once more want to call attention to the development in consumption, reported adverse reactions, age and dose recommendations.
-
14 May 2012 /Authorisation and supervision
-
10 May 2012 /Side effects and trials
-
09 May 2012 /About us
-
01 May 2012 /Side effects and trials
-
01 May 2012 /Authorisation and supervision
-
01 May 2012 /Side effects and trials
-
01 May 2012 /Side effects and trials
-
30 April 2012 /Authorisation and supervision
-
25 April 2012 /Retail and online sale
-
25 April 2012 /Side effects and trials
-
24 April 2012 /Authorisation and supervision
-
24 April 2012 /Authorisation and supervision
-
24 April 2012 /Authorisation and supervision
-
23 April 2012 /Side effects and trials
-
18 April 2012 /Authorisation and supervision
-
17 April 2012 /Authorisation and supervision
-
17 April 2012 /Authorisation and supervision
-
17 April 2012 /Authorisation and supervision

